Professor | Xingxing Diao | Asia Growth Partners

Name	Xingxing Diao
Contact Information	xxdiao@simm.ac.cn
Language ability	Chinese, English
Province	Shanghai

Name

Xingxing Diao

Contact Information

xxdiao@simm.ac.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2009-09--2014-07 PhD: University of Chinese Academy of Sciences 2005-09--2009-06 Bachelor's: Wuhan University
Work Experience	2019-02~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Group Leader 2018-08~2019-02 - Celgene Corporation, USA - Scientist II 2016-06~2018-08 - XenoBiotic Laboratories, USA - Scientist I/II 2014-07~2016-06 - National Institutes of Health (NIH), USA - Postdoctoral Researcher 2009-09~2014-07 - University of Chinese Academy of Sciences - PhD Student 2005-09~2009-06 - Wuhan University - Bachelor's Student
Awards	4th ISSX/CSSX Joint Meeting Second Prize (2013): Second Prize, Other 10th National Drug Analysis Excellent Paper Selection Third Prize (2011): Third Prize, Other

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

2009-09--2014-07 PhD: University of Chinese Academy of Sciences
2005-09--2009-06 Bachelor's: Wuhan University

Work Experience

2019-02~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Group Leader
2018-08~2019-02 - Celgene Corporation, USA - Scientist II
2016-06~2018-08 - XenoBiotic Laboratories, USA - Scientist I/II
2014-07~2016-06 - National Institutes of Health (NIH), USA - Postdoctoral Researcher
2009-09~2014-07 - University of Chinese Academy of Sciences - PhD Student
2005-09~2009-06 - Wuhan University - Bachelor's Student

Awards

4th ISSX/CSSX Joint Meeting Second Prize (2013): Second Prize, Other
10th National Drug Analysis Excellent Paper Selection Third Prize (2011): Third Prize, Other

Areas of Focus	Drug Metabolism Adverse Drug Reaction Mechanisms New Metabolic Pathways Uncommon Pharmacokinetics New Drug Metabolism Technologies Low-Radiation Energy Radioisotope Labeling Techniques in New Drug DMPK
Publications	Pharmacokinetics, mass balance, and metabolism of [14C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension, Xingxing Diao, 2022 Mechanistic study on the species differences in excretion pathway of HR011303 in human and rats, Xingxing Diao, 2022 Site-specific protein modification by 3-n-butylphthalide in primary hepatocytes: covalent protein adducts diminished by glutathione and N-acetylcysteine, Xingxing Diao, 2021

Areas of Focus

Drug Metabolism
Adverse Drug Reaction Mechanisms
New Metabolic Pathways
Uncommon Pharmacokinetics
New Drug Metabolism Technologies
Low-Radiation Energy Radioisotope Labeling Techniques in New Drug DMPK

Publications

Pharmacokinetics, mass balance, and metabolism of [14C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension, Xingxing Diao, 2022
Mechanistic study on the species differences in excretion pathway of HR011303 in human and rats, Xingxing Diao, 2022
Site-specific protein modification by 3-n-butylphthalide in primary hepatocytes: covalent protein adducts diminished by glutathione and N-acetylcysteine, Xingxing Diao, 2021

Drug Metabolism Adverse Drug Reaction Metabolic Pathways Pharmacokinetics Metabolism Technologies Radioisotope Labeling Dmpk Drug Analysis Toxicology Pharmacology

Xiaoyan Liao - Wuhan University

Jiang Yue - Wuhan University

Ru Hong Zhang - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us